Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 76.68 CHF 1.03% Market Closed
Market Cap: 38.1B CHF
Have any thoughts about
Alcon AG?
Write Note

Alcon AG
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alcon AG
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Alcon AG
SIX:ALC
Cash Interest Paid
$176m
CAGR 3-Years
19%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Cash Interest Paid
CHf933k
CAGR 3-Years
14%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Cash Interest Paid
CHf827.9k
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IVF Hartmann Holding AG
SIX:VBSN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alcon AG
Glance View

Market Cap
37.9B CHF
Industry
Health Care

Alcon AG, a leader in the global eye care industry, is dedicated to enhancing the quality of life for patients through innovative solutions and cutting-edge technologies. Formed in 1945, the company specializes in developing, manufacturing, and marketing surgical and vision care products that cater to a wide range of eye-related conditions. With a robust portfolio that includes advanced cataract surgery instruments, contact lenses, and dry eye treatments, Alcon has positioned itself as a formidable player in both the surgical and non-surgical segments of the market. The company's commitment to research and development ensures a steady stream of innovations, attracting a loyal customer base among healthcare professionals and patients alike. For investors, Alcon AG presents a compelling opportunity driven by its strong market presence and a favorable demographic backdrop, with an aging population increasingly in need of vision care solutions. The company has demonstrated consistent revenue growth and profitability, buoyed by strategic acquisitions and a willingness to invest in future growth areas, such as digital health and myopia management. Additionally, with a robust pipeline of products and a focus on expanding markets, Alcon is well-positioned to capitalize on the growing demand for eye care solutions. As it continues to navigate the evolving landscape of the healthcare sector, Alcon AG stands out as a promising investment for those seeking exposure to the eye care market.

ALC Intrinsic Value
73.08 CHF
Overvaluation 5%
Intrinsic Value
Price

See Also

What is Alcon AG's Cash Interest Paid?
Cash Interest Paid
176m USD

Based on the financial report for Dec 31, 2023, Alcon AG's Cash Interest Paid amounts to 176m USD.

What is Alcon AG's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
77%

Over the last year, the Cash Interest Paid growth was 59%. The average annual Cash Interest Paid growth rates for Alcon AG have been 19% over the past three years , 77% over the past five years .

Back to Top